Article
Cross-Species and Tissue-Agnostic Prediction of Human Cancer Treatment Response using AI-Powered Cellular Morphometric Biomarkers from a Genetically Diverse Erbb2 Mouse Model
2025-09-15
Abstract excerpt
The success of drug development relies heavily on the use of animal models. However, increasing evidence shows that discoveries in these models often fail to translate to human patients. In this study, we developed an AI framework to discovery cross-species and tissue-agnostic cellular morphometric biomarkers (CMBs) as a new avenue to improve translatability. Using this framework, we identified CMBs and CMB tumor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f249443c-900e-5fb5-8f22-225fd2f3d727
- DOI
- 10.1101/2025.09.15.25335730
